Work Here?
Adicet Bio develops cancer therapies using allogeneic gamma delta T cell therapies, which are immune cells designed to target and destroy cancer cells. Their approach utilizes donor-derived cells that are readily available, allowing for faster treatment compared to traditional methods that require a patient's own cells. The company focuses on serving healthcare providers, hospitals, and research institutions involved in cancer treatment. Adicet Bio's business model includes developing and commercializing its proprietary therapies, generating revenue through product sales and licensing agreements. A recent merger with resTORbio aims to enhance their technology and accelerate development. With significant funding, Adicet Bio is dedicated to improving cancer treatment outcomes through its unique immunotherapy approach.
Company Stage
IPO
Employees
51-200
Industries
Biotechnology, Healthcare
Total Funding
$141.6M
Headquarters
Redwood City, California
Founded
2014
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Flexible Work Hours
Paid Vacation
Paid Sick Leave
Paid Holidays
Parental Leave
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Wellness Program
Find jobs on Simplify and start your career today